文献速递瓣膜外科

原发性二尖瓣反流二尖瓣修复术长期结局的性别差异

Mitral Valve Repair for Primary Mitral Regurgitation: Long-Term Outcomes in Women vs Men.
PubMed 文献 · Ann Thorac Surg · 2026-04-01

单中心回顾性观察研究纳入2003至2012年因原发性二尖瓣反流行二尖瓣修复术的848例患者,女性占28.4%。女性长期生存率低于男性(10年77.3%对85.8%,20年57.6%对59.5%,P=.010),但校正后女性性别并非死亡危险因素,差异可归因于女性基线年龄更高;再手术累积发生率两性相当。

要点

  • 女性二尖瓣修复术后长期生存较差,主要归因于基线年龄更高而非女性性别本身。
  • 女性患者二尖瓣病变更复杂,前叶脱垂与瓣膜钙化比例高于男性。
  • 两性再手术累积发生率相当,10年与20年分别约12%与20%左右。

核心结论

  • 女性二尖瓣修复术后长期生存显著差于男性,但校正后女性性别并非死亡独立危险因素,差异可归因于女性基线年龄更高。
  • 尽管女性二尖瓣病变更为复杂,两性再手术累积发生率相当。

研究设计与样本

  • 单中心高容量中心回顾性观察研究,纳入2003至2012年因原发性二尖瓣反流行二尖瓣修复术的全部患者848例,女性占28.4%(n=241)。
  • 女性平均年龄61.8±13.6岁,男性56.9±11.4岁(P<.001);中位随访13.0年(四分位距8.8-15.5年)。

主要发现

  • 未校正分析中女性与男性生存差异显著:10年生存率77.3%对85.8%,20年生存率57.6%对59.5%(P=.010)。
  • 女性前叶脱垂(P=.018)与二尖瓣钙化(P=.022)的比例高于男性。
  • 死亡危险因素包括年龄(HR 1.101,P<.001)、心房颤动(HR 2.109,P=.007)及左心室射血分数<55%(HR 2.937,P<.001),女性性别无显著关联(HR 0.989,P=.947)。
  • 再手术累积发生率女性10年12.5%、20年20.7%,男性10年11.5%、20年22.3%(P=.859)。

临床怎么用

  • 评估女性二尖瓣修复候选者时应重视基线年龄及合并症(心房颤动、左心室射血分数<55%)对长期生存的影响。
  • 女性瓣膜病变更复杂但再手术率与男性相当,不应因性别而降低对女性行二尖瓣修复的信心。

局限性

  • 单中心回顾性观察设计,结果外推需谨慎。
  • 随访中部分临床变量可能不完整,混杂因素难以完全校正。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Female patients undergoing mitral valve surgery have worse short- and long-term survival compared with male patients. Less is known about long-term outcomes other than survival. METHODS: All patients who underwent mitral valve repair for primary mitral regurgitation from 2003 to 2012 at a single high-volume center were investigated. The aim of this retrospective, observational study was to investigate long-term survival, cumulative incidence of reoperation and recurrent mitral regurgitation, as well as sex differences in perioperative characteristics and at follow-up. RESULTS: A total of 848 patients were included, of whom 28.4% (n = 241) were female. The mean age was 61.8 ± 13.6 years for women and 56.9 ± 11.4 years for men (P < .001). Median follow-up was 13.0 (interquartile range, 8.8-15.5) years. Women were more often affected by anterior leaflet prolapse (P = .018) and calcification of the mitral valve (P = .022) than men. In unadjusted analysis, survival differed significantly for women and men: 10-year survival was 77.3% and 85.8%; 20-year survival was 57.6% and 59.5%, respectively (P = .010). However, female sex was not identified as risk factor for death (hazard ratio [HR], 0.989, P = .947), but age (HR, 1.101; P < .001), atrial fibrillation (HR, 2.109, P = .007), and reduced left ventricular ejection fraction <55% (HR, 2.937, P < .001) were. Cumulative incidence of reoperation at 10 and 20 years after mitral valve repair was 12.5% and 20.7% for women, and 11.5% and 22.3% for men (P = .859). CONCLUSIONS: Long-term survival was significantly worse for women, which can be attributed to higher age at baseline. Reoperation rates were comparable for all patients, although female patients presented with more complex mitral valve pathology.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lang M, Schmidt L, Doering M, et al. Mitral Valve Repair for Primary Mitral Regurgitation: Long-Term Outcomes in Women vs Men. Ann Thorac Surg. 2026. PMID: 41933781. doi:10.1016/j.athoracsur.2026.03.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。